Tarek Assi1, Elie El Rassy2, Aline Khazzaka3, Tania Moussa4, Tony Ibrahim2, Clarisse Kattan2, Fadi El Karak2, Fadi Farhat2, Marwan Ghosn2, Joseph Kattan2. 1. Department of Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. tarekassi@gmail.com. 2. Department of Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. 3. Surgical Research Laboratory, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. 4. Department of Radiology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
Abstract
BACKGROUND: The epidemiology of gastric cancer in the Middle East has never been described. Therefore, the characteristics of gastric cancer in the Lebanese population will be reported in this study. PATIENTS AND METHODS: A retrospective study that included all patients diagnosed with gastric cancer at Hotel Dieu de France University Hospital in Beirut, Lebanon between 2010 and 2016 was conducted. All eligible patients were reviewed for demographic and epidemiologic analysis. RESULTS: The study included 123 patients diagnosed with gastric cancer. The median age at diagnosis was 59 years (range 15-72 years), and the median ECOG performance status was 2 (range 1-4). Most patients were metastatic at diagnosis (52.8%), and diffuse pathology type was predominant (39%). HER2 was positive in 16.2% and correlated with the occurrence of hepatic metastasis (p = 0.048). The HER2 status did not differ significantly between the histological subtypes, the site of the tumor, the stage of the gastric cancer at diagnosis, and the recurrence of cancer (p > 0.05). CONCLUSION: Gastric cancer in the Lebanese population is characterized by aggressive features such as advanced stage at diagnosis, high prevalence of diffuse type histology, and HER2 positivity.
BACKGROUND: The epidemiology of gastric cancer in the Middle East has never been described. Therefore, the characteristics of gastric cancer in the Lebanese population will be reported in this study. PATIENTS AND METHODS: A retrospective study that included all patients diagnosed with gastric cancer at Hotel Dieu de France University Hospital in Beirut, Lebanon between 2010 and 2016 was conducted. All eligible patients were reviewed for demographic and epidemiologic analysis. RESULTS: The study included 123 patients diagnosed with gastric cancer. The median age at diagnosis was 59 years (range 15-72 years), and the median ECOG performance status was 2 (range 1-4). Most patients were metastatic at diagnosis (52.8%), and diffuse pathology type was predominant (39%). HER2 was positive in 16.2% and correlated with the occurrence of hepatic metastasis (p = 0.048). The HER2 status did not differ significantly between the histological subtypes, the site of the tumor, the stage of the gastric cancer at diagnosis, and the recurrence of cancer (p > 0.05). CONCLUSION:Gastric cancer in the Lebanese population is characterized by aggressive features such as advanced stage at diagnosis, high prevalence of diffuse type histology, and HER2 positivity.
Entities:
Keywords:
Diffuse histology; Gastric cancer; HER2; Lebanon; Middle East
Authors: Tarek Assi; Elie El Rassy; Samer Tabchi; Toni Ibrahim; Tania Moussa; Ralph Chebib; Fadi El Karak; Fadi Farhat; Georges Chahine; Fadi Nasr; Marwan Ghosn; Joseph Kattan Journal: Support Care Cancer Date: 2015-09-21 Impact factor: 3.603
Authors: Anna D Wagner; Wilfried Grothe; Johannes Haerting; Gerhard Kleber; Axel Grothey; Wolfgang E Fleig Journal: J Clin Oncol Date: 2006-06-20 Impact factor: 44.544
Authors: Paola Bertuccio; Liliane Chatenoud; Fabio Levi; Delphine Praud; Jacques Ferlay; Eva Negri; Matteo Malvezzi; Carlo La Vecchia Journal: Int J Cancer Date: 2009-08-01 Impact factor: 7.396
Authors: Hongyu Wu; Jennifer A Rusiecki; Kangmin Zhu; John Potter; Susan S Devesa Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-06-16 Impact factor: 4.254
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: H S Kim; H J Kim; S Y Kim; T Y Kim; K W Lee; S K Baek; T Y Kim; M H Ryu; B H Nam; D Y Zang Journal: Ann Oncol Date: 2013-08-13 Impact factor: 32.976
Authors: Joseph B Mabula; Mabula D McHembe; Mheta Koy; Phillipo L Chalya; Fabian Massaga; Peter F Rambau; Nestory Masalu; Hyasinta Jaka Journal: World J Surg Oncol Date: 2012-11-27 Impact factor: 2.754
Authors: Maan El Halabi; Renee Horanieh; Hani Tamim; Deborah Mukherji; Sara Jdiaa; Sally Temraz; Ali Shamseddine; Kassem Barada Journal: J Gastrointest Oncol Date: 2020-12